The Scottish Translational Medicine and Therapeutics Initiative (STMTI) is a novel collaboration between the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, funded by the Wellcome Trust with additional support from Pfizer Pharmaceuticals. It’s objective is to create a new cadre of academic clinicians with expertise in translational medicine and therapeutics through its PhD programme. Opportunities are available to undertake the first module of a Masters in Translational Medicine (Certificate Level) as part of this Initiative.
Further information is available from the Scottish Translational Medicine and Therapeutics Initiative website.
This article was published on Oct 14, 2010